breast cancer
The objectives of this trial were (1) to gain experience        with filgrastim given to patients with advanced breast cancer and receiving       standard-dose CNF, and (2) to determine the maximum tolerated dose of CNF that       could be given with filgrastim support by incremental dose escalation of two       components of the CNF regimen, cyclophosphamide and mitoxantrone.
The objectives of this trial were (1) to gain experience        with filgrastim given to  @OBJECT$   @PREDICAT$  advanced  @SUBJECT$  and receiving       standard-dose CNF, and (2) to determine the maximum tolerated dose of CNF that       could be given with filgrastim support by incremental dose escalation of two       components of the CNF regimen, cyclophosphamide and mitoxantrone.